Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation

References

• Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049–60.
   PubMed Web of Science ®Google Scholar
• Stevens LA, Levey AS. Chronic kidney disease in the elderly – how to assess risk. N Engl J Med 2005;352:2122–4.
   PubMed Web of Science ®Google Scholar
• Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Venge P, Ärnlöv J. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008;358:2107–16.
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Katz R, Fried LF, Siscovick D, Kestenbaum B, Seliger S, Rifkin D, Tracy R, Newman AB, Shlipak MG. Cystatin C and aging success. Arch Intern Med 2008;168:147–53.
   PubMedGoogle Scholar
• Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovascular risk. Clin Chem 2009;55:1932–43.
   PubMed Web of Science ®Google Scholar
• Jernberg T, Lindahl B, James S, Larsson A, Hansson LO, Wallentin L. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 2004;110:2342–8.
   PubMed Web of Science ®Google Scholar
• Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function – measured and estimated glomerular filtration rate. N Engl J Med 2006;354:2473–83.
   PubMed Web of Science ®Google Scholar
• Rifkin DE, Katz R, Chonchol M, Fried LF, Cao J, deBoer IH, Siscovick DS, Shlipak MG, Sarnak MJ. Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. Nephrol Dial Transplant 2010;25:1560–7.
   PubMed Web of Science ®Google Scholar
• Perkins BA, Nelson RG, Krolewski AS. Cystatin C and the risk of death. N Engl J Med 2005;353:843.
   Google Scholar
• Koenig W, Twardella D, Brenner H, Rothenbacher D. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 2005;51:321–7.
   PubMed Web of Science ®Google Scholar
• Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul study. Nephrol Dial Transplant 2007;22:1087–92.
   PubMed Web of Science ®Google Scholar
• Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, Cummings SR, Harris TB, Shlipak MG. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int 2007;71:239–44.
   PubMed Web of Science ®Google Scholar
• Knight EL, Verhave JC, Spiegelman D, Hillege HL, deZeeuw D, Curhan GC, deJong PE. Factors influencing cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004;65:1416–21.
   PubMed Web of Science ®Google Scholar
• Dati F, Schumann G, Thomas L, Aguzzi F, Baudner S, Bienvenu J, Blaabjerg O, Blirup-Jensen S, Carlström A, Hyltoft-Petersen P, Johnson AM, Milfor-Ward A, Ritchie R, Just Svendsen P, Whicher J. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP reference material (CRM 470). Eur J Clin Chem Clin Biochem 1996;34:517–20.
   PubMedGoogle Scholar
• Hutchinson WL, Koenig W, Fröhlich M, Sund M, Lowe GDO, Pepys MB. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem 2000;46:934–8.
   PubMed Web of Science ®Google Scholar
• Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindström V, Grubb A. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994;40:1921–6.
   PubMed Web of Science ®Google Scholar
• Norlund L, Fex G, Lanke J, von Schenck H, Nilsson JE, Leksell H, Grubb A. Reference intervals for the glomerular filtration and cell-proliferation markers: serum cystatin C and serum beta-2-microglobulin/cystatin C ratio. Scand J Clin Lab Invest 1997;57:463–70.
   PubMed Web of Science ®Google Scholar
• Rothkrantz-Kos S, Schmitz MP, van Dieijen-Visser MP. Analytical evaluation and reference values of serum amyloid-A on the BN ProSpec. Clin Chem Lab Med 2004;42:973–5.
   Google Scholar
• Poole S, Walker D, Gaines Das RE, Gallimore JR, Pepys MB. The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study. J Immunol Methods 1998;214:1–10.
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, van Lente F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247–54.
   PubMed Web of Science ®Google Scholar
• Pottel H, Vrydags N, Mahieu B, Vandewynckele E, Croes K, Martens F. Establishing age/sex related serum creatinine reference intervals from hospital laboratory data based on different statistical methods. Clin Chim Acta 2008;396:49–55.
   PubMed Web of Science ®Google Scholar
• Grubb A. Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: simultaneous use of cystatin C- and creatinine-based GFR-prediction equations, clinical data and an internal quality check. Scand J Clin Lab Invest 2010;70:65–70.
   PubMed Web of Science ®Google Scholar
• Grubb A, Lindström V, Kristensen K, Christensson A, Wide-Swensson D, Strevens H, Schmidt C, Blirup-Jensen S. Filtration quality: a new measure of renal disease. Clin Chem Lab Med 2007;45:(Suppl. S2):73–4.
   Google Scholar
• Strevens H, Wide-Swensson D, Torffvit O, Grubb A. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest 2002;62:141–8.
   PubMed Web of Science ®Google Scholar
• Roberts M, Lindheimer MD, Davison JM. Altered glomerular permselectivity to neutral dextrans and heteroporous membrane modeling in human pregnancy. Am J Physiol 1996;270:F338–43.
   PubMed Web of Science ®Google Scholar
• Okura T, Jotoku M, Irita J, Enomoto D, Nagao T, Desilva VR, Yamane S, Pei Z, Kojima S, Hamano Y, Mashiba S, Kurata M, Miyoshi K, Higaki J. Association between cystatin C and inflammation in patients with essential hypertension. Clin Exp Nephrol 2010;14:358–63.
   Google Scholar
• Al-Maliki N, Heidenheim PA, Filler G, Yasin A, Lindsay RM. Cystatin C levels in functionally anephric patients undergoing dialysis: the effect of different methods and intensities. Clin J Am Soc Nephrol 2009;4:1606–10.
   Google Scholar